Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 3;4(23):101523.
doi: 10.1016/j.jaccas.2022.06.013. eCollection 2022 Dec 7.

Heart-Kidney Transplantation in a Transgender Woman

Kristen Lee  1 , Sarah Chuzi  2 , Joshua Katz  3 , Alyssa Vela  4 , Heather Wilson  4 , Jane E Wilcox  2 , Kambiz Ghafourian  2 , Clyde W Yancy  2 , Lauren Beach  5 , Duc Thinh Pham  4
Affiliations
Case Reports

Heart-Kidney Transplantation in a Transgender Woman

Kristen Lee et al. JACC Case Rep. .

Abstract

We describe the care of a transgender woman with heart failure who underwent heart-kidney transplantation. Perioperative management of hormone therapy, considerations for future gender-affirming surgeries, and psychosocial aspects of care are discussed. Interdisciplinary collaboration is essential in the treatment of patients with advanced heart failure in the setting of gender-affirming therapies. (Level of Difficulty: Advanced.).

Keywords: HF, heart failure; awareness; cardiac transplantation; systolic heart failure; thrombosis.

PubMed Disclaimer

Conflict of interest statement

Dr. Wilcox has received consultative fees from Amgen, Abbott, Abiomed, and Novartis; and serves on the scientific advisory boards for Abiomed and Cytokinetics. Dr. Pham has received consultative fees from Medtronic, Abbott, and Abiomed. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Strategies for Ensuring Gender-Affirming Care in Advanced Heart Failure
See this image and copyright information in PMC

References

    1. Totaro M., Palazzi S., Castellini C., et al. Risk of venous thromboembolism in transgender people undergoing hormone feminizing therapy: a prevalence meta-analysis and meta-regression study. Front Endocrinol. 2021;12 - PMC - PubMed
    1. Tangpricha V., den Heijer M. Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol. 2017;5(4):291–300. - PMC - PubMed
    1. Connelly P.J., Marie Freel E., Perry C., et al. Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults. Hypertension. 2019;74(6):1266–1274. - PMC - PubMed
    1. Kirklin J.K., Xie Rongbing X., Cowger J., et al. Second annual report from the ISHLT mechanically assisted circulatory support registry. J Heart Lung Transplant. 2018;37(6):685–691. - PubMed
    1. Prior J.C., Vigna Y.M., Watson D. Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Arch Sex Behav. 1989;18(1):49–57. - PubMed

Publication types